U.S. Capital Markets Stock News

Chesapeake Utilities is anticipated to post a 17.4% revenue decline for the quarter ending September 30, 2025, with analysts estimating earnings of US$0.92 per share. While a revenue drop is expected, analysts continue to maintain a positive outlook on the company, signaling confidence in Chesapeake Utilities' fundamentals despite short-term headwinds. We'll explore how expectations of a quarterly revenue decline may influence Chesapeake Utilities' longer-term business outlook and investment...

Valaris Limited reported its third quarter 2025 results, with net income rising to US$188.1 million despite sales declining to US$595.7 million, and announced it had completed the repurchase of 9.35% of its shares since 2022. This combination of higher earnings and substantial share repurchases stands out at a time when the company saw lower year-over-year revenue. We’ll explore how the significant increase in net income amid ongoing share buybacks could influence Valaris’s investment...

Vaxcyte recently reported financial results for the third quarter and nine months ended September 30, 2025, revealing a net loss of US$212.83 million for the quarter, more than doubling compared to the same period last year. An important detail is that basic and diluted loss per share for both the quarter and year-to-date also increased, highlighting a greater gap between expenses and potential revenue. We'll explore how the widening net losses and per-share results may influence Vaxcyte's...

EastGroup Properties, Inc. recently announced its third quarter and nine-month 2025 earnings, reporting higher revenue and net income compared to the same periods last year, and issued updated earnings guidance for the fourth quarter and full year 2025. A key takeaway from these results is the continued revenue and net income growth, highlighting strong operational performance amid ongoing demand for logistics real estate in the company's core Sunbelt markets. We'll explore how this...

Colgate-Palmolive reported stronger-than-expected third-quarter earnings. However, management trimmed its annual sales outlook due to softer demand and higher costs. The update reflects persistent challenges facing consumer brands in today's market. See our latest analysis for Colgate-Palmolive. The mixed earnings news, combined with a trimmed sales outlook, has kept pressure on Colgate-Palmolive’s shares. After sliding steadily through 2025, the stock is now trading at $76.55, down 15.5% for...

Elme Communities (NYSE:ELME) just posted its third quarter results, revealing a significant net loss along with a large real estate impairment charge. Both announcements highlight real financial pressure for shareholders at this time. See our latest analysis for Elme Communities. After its quarterly update showing a significant net loss and real estate impairment, Elme Communities’ stock has shown some resilience, holding a 9.6% year-to-date share price return despite these challenges...

Tutor Perini Corporation announced last week that it will report its Q3 2025 earnings results after market close on November 5, 2025, with analysts anticipating revenue to reach US$1.38 billion, a 27.8% increase year over year. An interesting insight is that Tutor Perini has consistently exceeded Wall Street's revenue estimates every quarter since going public, with an average beat of 12.6%. We'll explore how heightened analyst optimism and raised full-year estimates ahead of the earnings...

If you’re wondering whether Adobe stock is a bargain or overpriced in today’s market, you’re not alone. Recent volatility has caught the attention of many investors looking for value. Adobe’s share price has dropped 6.8% over the past week and is down 24.0% year-to-date, with a 31.1% loss over the past year. These moves raise questions about what is driving the decline and whether new opportunities may be developing. Much of this recent movement has been shaped by ongoing stories in the tech...

United Parks & Resorts (PRKS) recently announced that James Mikolaichik will step down as Chief Financial Officer and Treasurer on November 15, 2025. Senior finance executive Jim Forrester will assume both roles on an interim basis. See our latest analysis for United Parks & Resorts. The leadership changes at United Parks & Resorts shook up the market, with the one-week share price return sliding 10.2%, as investors digested the news of the long-serving CFO departing. Over the past year,...

V.F. Corporation recently reported second quarter earnings, with sales of US$2,802.71 million and net income of US$189.77 million, and declared a quarterly dividend of US$0.09 per share payable in December 2025. While profitability showed strong improvement over the period, the company’s revenue guidance for the upcoming quarter points to a slight year-over-year decline. We'll explore how V.F.'s improved profitability and continued dividend commitment influence the investment...

Ever wondered if Plains All American Pipeline stock could be a hidden gem or if you might be chasing it past its prime? You're not alone, and looking at current value is more important than ever. While shares are up a solid 220.0% over the past five years, this year has seen a -5.1% dip so far, with short-term returns also trending lower. Much of the recent share price movement has been driven by industry buzz around infrastructure upgrades and changes in energy demand, with several notable...

In the past week, Floor & Decor Holdings announced third-quarter results showing increased sales and net income, alongside updated full-year earnings guidance and a planned CEO transition, with President Bradley Paulsen set to become CEO in December 2025 as the current CEO moves to Executive Chair. The leadership change, paired with continued growth in quarterly performance, highlights a focus on both operational continuity and the company's targets for long-term expansion toward 500...

UFP Technologies (UFPT) reported net profit margins of 11.2%, down from 11.7% a year ago, with recent annual earnings growth of 23.8% underperforming its five-year average of 31.6%. Looking ahead, earnings are forecast to rise at 14.33% per year and revenue growth is expected at 5.6% annually, which trails the broader US market’s 10.5% projected pace. While the company's Price-to-Earnings Ratio of 25.6x sits below the US Medical Equipment industry average but above its peer group, shares are...

RadNet recently reported quarterly results that surpassed expectations, raising its 2025 guidance and highlighting ongoing imaging volume growth, increased revenue, and improved operational efficiency through AI-enabled technologies. A particularly relevant development is the company’s intent to commercialize comprehensive remote imaging services following its acquisition of Alpha RT’s assets, which integrates staffing solutions and AI safety monitoring with DeepHealth’s advanced...

Wondering if Kennedy-Wilson Holdings is now a value play or if there is more trouble ahead? Let’s dive in and see whether curiosity is rewarded. The stock has tumbled in 2024, dropping 24.7% year-to-date and losing over 28% across the last twelve months as investor sentiment has shifted quickly. Recent headlines have centered on industry-wide volatility in real estate, with rising interest rates and macro uncertainty putting pressure on REITs and property holding firms like Kennedy-Wilson...

Exponent (EXPO) caught market attention after it posted higher revenue and net income for the recent quarter. The company also announced a $100 million boost to its share repurchase program and reaffirmed its dividend. See our latest analysis for Exponent. Although Exponent’s extra buyback firepower and stable dividend have provided a recent boost to sentiment, momentum is still building after a tough year. The stock has climbed 6.9% over the past month as investors warmed to improving...

Kyndryl Holdings recently reported results for the quarter and six months ended September 30, 2025, showing a move to net income of US$68 million for the quarter, up from a net loss a year earlier, and reaffirmed guidance for revenue growth through March 2026. This marks a key turnaround for the company, as both quarterly and first-half earnings swung from losses to profits despite a modest decline in sales, while management highlighted expectations for stronger revenue in the second half...

Pacira BioSciences recently announced an exclusive global licensing and collaboration agreement with AmacaThera to develop AMT-143, a novel long-acting non-opioid analgesic for postsurgical pain control, and released updated three-year clinical results for PCRX-201, its gene therapy candidate for osteoarthritis of the knee, highlighting consistent safety and efficacy. These developments spotlight Pacira’s efforts to expand its pipeline through innovation and partnerships, strengthening its...

Ever wondered if DraftKings is a bargain right now, or if you’ve missed your shot? Let’s dig into the numbers and see if there’s real value hiding behind the buzz. Despite some rollercoaster moments, DraftKings has dropped 21.5% over the last year and is down even more over the past month. Look closer and you’ll spot a massive 128.0% gain over three years, which signals that growth questions are still on the table. Recently, the stock has been moving in response to broader trends in online...

Wondering if Qiagen is a smart buy right now? You are not alone, as there has been a lot of chatter lately about whether the current share price offers real value to investors. The stock has dipped 7.9% in the past week and 5.6% over the last month, with a somewhat muted 3.6% decline year-to-date. However, it has managed to eke out a modest 1.0% gain over the past year. Qiagen has caught attention recently with its ongoing innovations in biotech solutions and a series of new product...

Applied Materials recently attracted attention as institutional investors increased their holdings ahead of its upcoming earnings report, which is expected on November 13, 2025, with consensus forecasts of a year-over-year earnings and revenue decline. Despite expectations for weaker financial results, heightened institutional interest and mixed analyst sentiment highlight ongoing debate about the company's prospects amid industry shifts. To understand how increased institutional positioning...

Curious if Griffon is worth your attention right now? Let's dig into the numbers and see if there's real value here, or if the stock's price has run too far ahead. Even after a slight pullback of -3.7% over the last week and -5.1% in the past month, Griffon's stock is still up 2.6% year-to-date and an impressive 15.2% over the past year. This suggests possible growth momentum, but it also indicates shifting market sentiment around its future prospects. Recent headlines highlight Griffon's...

Ross Stores (ROST) shares have seen steady momentum this month, up a little over 6%, even though there has been no headline-making event driving the stock. Investors may be watching for fresh catalysts as the year unfolds. See our latest analysis for Ross Stores. Ross Stores has been building a steady head of steam for much of the past year, with its 1-year total shareholder return reaching 15.26% and a 30-day share price return of 6.3% hinting at renewed optimism around the stock’s outlook...

WEC Energy Group recently filed a US$3 billion follow-on equity offering and announced third-quarter results showing year-over-year growth in both sales and net income. The combination of fresh equity issuance and reaffirmed full-year earnings guidance signals an ongoing commitment to infrastructure investment while also raising considerations around share dilution and capital allocation. We will explore how WEC’s capital raise, spotlighted by this sizable equity offering, interacts with its...